Take this medicine in the dose and duration as advised by your doctor. Check the label for directions before use. Measure it with a measuring cup and take it by mouth. Shake well before use. Kasiza Syrup may be taken with or without food, but it is better to take it at a fixed time.
Kasiza Syrup is a combination of three medicines: Ambroxol, Guaifenesin and Terbutaline which relieve cough with mucus. Ambroxol is a mucolytic which thins and loosens mucus (phlegm), making it easier to cough out. Guaifenesin is an expectorant which decreases the stickiness of mucus (phlegm) and helps in its removal from the airways. Terbutaline is a bronchodilator. It works by relaxing the muscles in the airways and widens airways. Together, they make breathing easier.
Interaction with alcohol is unknown. Please consult your doctor.
WEIGH RISKS VS BENEFITS
Kasiza Syrup may be unsafe to use during pregnancy. Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
No information is available on the use of Kasiza Syrup during lactation. Please consult your doctor.
It is not known whether Kasiza Syrup alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Kasiza Syrup should be used with caution in patients with kidney disease. Dose adjustment of Kasiza Syrup may be needed. Please consult your doctor.
Kasiza Syrup should be used with caution in patients with liver disease. Dose adjustment of Kasiza Syrup may be needed. Please consult your doctor. Limited information is available on the use of Kasiza Syrup in these patients.
“The following are the results of on-going survey on 1mg.com for Kasiza Syrup. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”
Information last updated by Dr. Varun Gupta, MD Pharmacology on 6th Feb 2018.